The FTSE 100 has enjoyed its best month in 31 years. Britain’s blue-chip index gained 12.4% in November, adding more than £180bn to its market value. You would have to go back to January 1989 to find a more profitable month for UK investors.
Despite the gains, the FTSE 100 remains down 16% so far this year. The UK market “has been a dog” ever since the 2016 Brexit vote, says Russ Mould for AJ Bell. But as any investor knows, the aim of the game is to “buy low” and sell high. Bargain-hunters sense opportunity. There have been 14 takeover deals in the past month alone. To quote the writer Joseph Campbell, “the cave you fear to enter holds the treasure you seek”.
Private-equity firms have accumulated a global war chest estimated at $2.5trn, says Ben Martin in The Times. Recent bids for the AA and McCarthy & Stone show they are ready to spend in London. Data from Peel Hunt shows that there have been £22.8bn-worth of bids for London-listed firms since the start of August, never mind the awkwardness of negotiating a multimillion-pound acquisition over Zoom.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
There could be more to come. Some potential buyers are reportedly holding back while London and Brussels hash out a deal. When there is more clarity on that point, they stand ready to swoop.
-
Working from home: is it working?While Labour plans to make working from home the legal default, some employers are calling workers back into the office. What does the future hold?
-
International Investment Summit: will the government's growth plans boost investor portfolios?News The government is looking to attract investment into UK projects. We explain what this could mean for your money
-
Keir Starmer's 100 days in office: chaos and miseryKeir Starmer has achieved 100 days in office. The bumbling and grasping prime minister needs a guiding mission
-
Pfizer shares rise as US investor takes $1 billion stakePfizer shares are on the up since US activist investor Starboard Value built up a stake in the drug maker. But strategic options appear limited
-
Qualcomm could acquire rival Intel – but securing the deal won't be easyA tie-up between Qualcomm and its semiconductor rival Intel would be a coup. But multiple regulatory and commercial hurdles lie ahead.
-
Modi’s reforms set Indian stocks on fireIndian stocks pass a new milestone, but global fund managers are holding back. Are there signs of overheating?
-
How to invest in the quiet market monthsHere's how to invest in the quiet market months, since “sell in May” hasn’t paid off this year.
-
Spire Healthcare: invest in the booming demand for private healthcareSpire Healthcare is one of the few listed companies benefiting from the growing trend in private healthcare. Should you invest?
-
Are insurance companies a good investment?Costs may be soaring but the insurance sector is currently going through one of its most profitable periods. The market has been slow to realise the opportunity here
-
Dr Martens shares slump: should you give it the boot?Over the past three years, Dr Martens has fallen out of fashion. Are the shares worth a look?
